Tarsus Pharmaceuticals (TARS) PT Raised to $95 at Oppenheimer
Tweet
Share
E-mailGet Alerts TARS Hot Sheet
Price: $69.20 +0.46%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Oppenheimer analyst Suraj Kalia raised the price target on Tarsus Pharmaceuticals (NASDAQ: TARS) to $95.00 (from $75.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Tarsus Pharmaceuticals (TARS) PT Raised to $100 at Oppenheimer
- Lithium Ionic Corp (LTH:CN) PT Lowered to Cdn$2.50 at Desjardins
- GMR Airports Infrastructure (GMRI:IN) PT Raised to INR99 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
